Monday, December 04, 2017 12:30:49 PM
Authorized Shares: 2,100,000,000 - as at Nov 30, 2017 [no change]
Outstanding Shares: 1,830,612,000 - as at Nov 30, 2017 [reduced by 30,000,000 since January 30, 2017]
Restricted: 208,800,000 - as at Nov 30, 2017 [no change].
Unrestricted: 1,621,812,000 - as at Nov 30, 2017 [no change].
Held at DTC: 1,440,941,334 - as at Nov 30, 2017 [425M retired since May 31, 2017 - 150M retired May 31 > Jul 31 - 275M retired Jul 31 > Oct 31 - total 425M = very good - not available to individual investors].
Float: 1,621,812,000 - as at Sep 30, 2017 [reduced by 50,000,000 since December 31, 2016]
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM